ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,325.57
0.01%
Brent Oil
85.215
0.12%
Bitcoin
63,241.29
0.91%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Scinai Immunotherapeutics Ltd (SCNI) Share Price

SCNI Scinai Immunotherapeutics Ltd

2.76
-0.10 (-3.50%)
29 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Scinai Immunotherapeutics Ltd NASDAQ:SCNI NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.10 -3.50 2.76 2.75 4.80 3.0381 2.65 2.9 49,105 04:00:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 9k -6.5M - N/A 
 Type  Size  Price  Time  Units 
 9 5 2.7501 23:59:54 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SCNI News
14/06/202412:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
13/06/202415:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
13/06/202415:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
13/06/202412:00PRNUSScinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.
07/06/202412:00PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement
28/05/202419:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
24/05/202421:01PRNUSScinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance
Period
Draw mode
Data Downloads for SCNI

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Scinai Immunotherapeutics Ltd Articles